96 related articles for article (PubMed ID: 24681545)
1. A macroprolactin level today may keep health care cost and the surgical knife at bay.
Henry RK; Bowden SA
Clin Pediatr (Phila); 2015 Mar; 54(3):283-5. PubMed ID: 24681545
[No Abstract] [Full Text] [Related]
2. Effects of ethinyl estradiol and desogestrel on clinical and metabolic parameters in Indian patients with polycystic ovary syndrome.
Bhattacharya SM; Ghosh M; Basu R
J Obstet Gynaecol Res; 2012 Jan; 38(1):285-90. PubMed ID: 22070369
[TBL] [Abstract][Full Text] [Related]
3. [Polycystic ovary syndrome associated with remarkable hyperprolactinemia--case report].
Owecki M; Sowiński J
Pol Merkur Lekarski; 2004 Oct; 17(100):385-7. PubMed ID: 15690710
[TBL] [Abstract][Full Text] [Related]
4. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
[TBL] [Abstract][Full Text] [Related]
5. Macroprolactinemia in women presenting with hyperandrogenic symptoms: Implications for the management of polycystic ovary syndrome.
Escobar-Morreale HF
Fertil Steril; 2004 Dec; 82(6):1697-9. PubMed ID: 15589886
[TBL] [Abstract][Full Text] [Related]
6. Prolactin response to clomiphene citrate is different in hyperprolactinemic polycystic ovary syndrome and idiopathic hyperprolactinemia.
Lewinthal D; Corenblum B; Taylor PJ
Int J Fertil; 1987; 32(3):185-7, 191. PubMed ID: 2885281
[No Abstract] [Full Text] [Related]
7. Importance of macroprolactinemia in hyperprolactinemia.
Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
[TBL] [Abstract][Full Text] [Related]
8. Hyperprolactinemia in children during the peripubertal period--personal observations.
Noczyńska A; Wasikowa R
J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1399-404. PubMed ID: 15526718
[TBL] [Abstract][Full Text] [Related]
9. Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.
Kriplani A; Periyasamy AJ; Agarwal N; Kulshrestha V; Kumar A; Ammini AC
Contraception; 2010 Aug; 82(2):139-46. PubMed ID: 20654754
[TBL] [Abstract][Full Text] [Related]
10. Current evaluation of amenorrhea.
Practice Committee of the American Society for Reproductive Medicine
Fertil Steril; 2006 Nov; 86(5 Suppl 1):S148-55. PubMed ID: 17055812
[TBL] [Abstract][Full Text] [Related]
11. [Relation between hyperprolactinemia and polycystic ovary syndrome].
Hámori M; Szendei G; Kovács I; Somos P
Zentralbl Gynakol; 1987; 109(8):481-6. PubMed ID: 3111126
[TBL] [Abstract][Full Text] [Related]
12. Serum high-sensitivity C-reactive protein and homocysteine changes during hormonal therapy in women with polycystic ovary syndrome: a prospective, matched study.
Makedos A; Goulis DG; Papanikolaou A; Panidis D
Angiology; 2010 Aug; 61(6):595-601. PubMed ID: 20395229
[TBL] [Abstract][Full Text] [Related]
13. [Physiopathological link between polycystic ovary syndrome and hyperprolactinemia: myth or reality?].
Robin G; Catteau-Jonard S; Young J; Dewailly D
Gynecol Obstet Fertil; 2011 Mar; 39(3):141-5. PubMed ID: 21388855
[TBL] [Abstract][Full Text] [Related]
14. [Long-term treatment with hormones in gynecology].
Hohlweg W; Reiffenstuhl G
Wien Klin Wochenschr; 1965 Nov; 77(44):878-81. PubMed ID: 5895017
[No Abstract] [Full Text] [Related]
15. [Mastopathy in amenorrhea patients].
Serov VN; Prilepskaia VN; Samoĭlova TE
Akush Ginekol (Mosk); 1986 Nov; (11):13-5. PubMed ID: 2949640
[No Abstract] [Full Text] [Related]
16. Skin improvement with two different oestroprogestins in patients affected by acne and polycystic ovary syndrome: clinical and instrumental evaluation.
Colonna L; Pacifico V; Lello S; Sorge R; Raskovic D; Primavera G
J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1364-71. PubMed ID: 22011217
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary syndrome or hyperprolactinaemia: a study of mild hyperprolactinaemia.
Su HW; Chen CM; Chou SY; Liang SJ; Hsu CS; Hsu MI
Gynecol Endocrinol; 2011 Jan; 27(1):55-62. PubMed ID: 20504100
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey.
Johnsen E; Kroken RA; Abaza M; Olberg H; Jørgensen HA
J Clin Psychopharmacol; 2008 Dec; 28(6):686-90. PubMed ID: 19011438
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
Shi YH; Sheng Y; Chen ZJ; Yan JH; Gao Q; Liu H; Ma ZX
Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):251-3. PubMed ID: 18843962
[TBL] [Abstract][Full Text] [Related]
20. [Amenorrhea and its management].
Staemmler HJ
Dtsch Med Wochenschr; 1968 May; 93(18):924-5. PubMed ID: 5646134
[No Abstract] [Full Text] [Related]
[Next] [New Search]
